Clinical Trial Update: DNA Repair Inhibitor & Irradiation on Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a DNA repair inhibitor in combination with irradiation for melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• DNA Repair Inhibitor (DNA repair inhibitor)

Snippet

Sponsor: DNA Therapeutics | Conditions: Local Metastatic Melanoma | Phase 1 | Status: COMPLETED